Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus

Loss of ovarian 17β-estradiol (E2) in postmenopause is associated with gut dysbiosis, inflammation, and increased risk of cardiometabolic disease and osteoporosis. The risk-benefit profile of hormone replacement therapy is not favorable in postmenopausal women therefore better treatment options are...

Full description

Bibliographic Details
Main Authors: Ke Sui, Kevin M. Tveter, Fiona G. Bawagan, Patricia Buckendahl, Savannah A. Martinez, Zehra H. Jaffri, Avery T. MacDonell, Yue Wu, Rocio M. Duran, Sue A. Shapses, Diana E. Roopchand
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.900667/full